The U.S. Food and Drug Administration (FDA) has granted approval for a novel combination antibiotic, Emblaveo. This unique formulation, combining aztreonam and avibactam, is the first-of-its-kind monobactam/β-lactamase inhibitor mix. Set to be commercially available by the third quarter of 2025, this antibiotic solution aims to provide a therapeutic option for patients who have limited or…
Health officials from Northeast Ohio are intensifying their calls for people to explore recently approved vaccines against the seasonal respiratory syncytial virus (RSV). Over the past few months, several RSV vaccines have secured approval from the Food and Drug Administration (FDA), with a specific focus on safeguarding infants and elderly individuals. Erin Murphy, who oversees…